Skip to main content

Published locations for FDA approves first PARP inhibitor for early BRCA+ breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves first PARP inhibitor for early BRCA+ breast cancer

User login

  • Reset your password
  • /content/fda-approves-first-parp-inhibitor-early-brca-breast-cancer
  • /fedprac/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early-brca-breast
  • /internalmedicinenews/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early
  • /obgynnews/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early-brca
  • /oncologypractice/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early
  • /fedprac/avaho/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early-brca
  • /jcomjournal/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early-brca
  • /obgyn/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early-brca-breast
  • /hematology-oncology/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early
  • /internalmedicine/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early
  • /breast-cancer-icymi/article/252785/metastatic-breast-cancer/fda-approves-first-parp-inhibitor-early